Akèy › Rosase
Etid klinik pou Rosase ap rekrite nan Etazini
5 etid pou Rosase ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07681271Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT07600424Rosacea Radiofrequency Microneedling
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06801717Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT06312813Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2025 · NCT06952517Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.